PHARMA MAR SA innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	United Kingdom	136
#2	EPO (European Patent Office)	106
#3	United States	82
#4	WIPO (World Intellectual Property Organization)	79
#5	Australia	73
#6	Canada	69
#7	Israel	61
#8	China	57
#9	Mexico	45
#10	Brazil	36
#11	Republic of Korea	35
#12	Hong Kong	30
#13	Norway	26
#14	South Africa	24
#15	New Zealand	21
#16	Japan	20
#17	Ukraine	18
#18	Serbia	15
#19	Hungary	14
#20	Argentina	11
#21	Slovakia	10
#22	Singapore	9
#23	Bulgaria	8
#24	Malaysia	8
#25	Montenegro	7
#26	Poland	6
#27	Taiwan	6
#28	EAPO (Eurasian Patent Organization)	5
#29	Spain	5
#30	Chile	4
#31	Slovenia	3
#32	Uruguay	3
#33	Jordan	2
#34	Morocco	2
#35	Peru	2
#36	Colombia	1
#37	Germany	1
#38	Ecuador	1
#39	Honduras	1
#40	Luxembourg	1
#41	Netherlands	1
#42	African Intellectual Property Organization	1
#43	Panama	1
#44	Philippines	1
#45	Portugal	1
#46	Russian Federation	1
#47	El Salvador	1

#	Technology
#1	Therapeutic chemical compounds
#2	Medical preparations
#3	Heterocyclic compounds
#4	Peptides
#5	Climate change mitigation in goods production
#6	Acyclic or carbocyclic compounds
#7	Special acyclic compounds
#8	Climate change adaptation technologies
#9	Fermentation
#10	Steroids

#	Name	Total Patents
#1	Manzanares Ignacio	120
#2	Cuevas Marchante Maria Del Carmen	101
#3	Cuevas Carmen	92
#4	Francesch Solloso Andres	85
#5	Munt Simon	74
#6	Gallego Pilar	74
#7	Reyes Benitez Jose Fernando	65
#8	Faircloth Glynn Thomas	54
#9	Aviles Marin Pablo Manuel	52
#10	Fernandez Rodriguez Rogelio	51

Publication	Filing date	Title
WO2021043951A1	2020-09-04	Drug antibody conjugates
WO2021043949A1	2020-09-03	Lurbinectedin in the treatment of malignant mesothelioma
WO2020239478A1	2020-05-15	Trabectedin for treating sarcomas based on genomic markers
UY38516A	2019-12-17	ANTITUMOR COMPOUNDS
TW202034957A	2019-10-23	Drug antibody conjugates
TW201906850A	2018-04-27	Antitumor compound
MX2019010890A	2018-03-16	Anticancer compounds.
WO2014108526A1	2014-01-13	Synthetic process for the manufacture of pipecolidepsin compounds
AU2012216670A1	2012-09-05	Antitumoral compounds
CN103282037A	2011-11-11	Combination therapy with an antitumor alkaloid
AU2011203085A1	2011-06-24	Antitumoral dihydropyran-2-one compounds
AU2011257277A1	2011-05-24	Synthetic process for the manufacture of ecteinascidin compounds
AU2011247634B2	2011-04-26	Anticancer steroidal lactones unsaturated in position 7 (8)
WO2011048210A1	2010-10-22	PDGFR-α AS RESPONSE MARKER FOR PM00104 TREATMENT
MX2011006532A	2009-12-18	Anticancer compounds.
WO2010029158A1	2009-09-11	Aplidine in the treatment of chronic myeloproliferative disorders
EP2318428A1	2009-07-16	Anticancer compounds
KR20110043653A	2009-07-02	Antitumoral macrolides
MX2010012501A	2009-05-18	Combination therapy with pm00104 and another antitumor agent.
WO2009135939A2	2009-05-08	Pm02734 for use in the treatment of ewing' s sarcoma, osteosarcoma, rhabdomyosarcoma and medulloblastoma